Mallinckrodt to Showcase Groundbreaking Research on TERLIVAZ® at the 2025 Digestive Disease Week Mallinckrodt plc will present significant research on its drug TERLIVAZ® at the 2025 DDW, focusing on hepatorenal syndrome and its effects on kidney function.

Mallinckrodt to Showcase Groundbreaking Research on TERLIVAZ® at the 2025 Digestive Disease Week #United_States #San_Diego #Mallinckrodt #TERLIVAZ #Digestive_Disease_Week